Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.

We recently showed that differential expression of extracellular matrix (ECM) genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4) with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted uns...

Full description

Bibliographic Details
Main Authors: Tiziana Triulzi, Patrizia Casalini, Marco Sandri, Manuela Ratti, Maria L Carcangiu, Mario P Colombo, Andrea Balsari, Sylvie Ménard, Rosaria Orlandi, Elda Tagliabue
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3575489?pdf=render
_version_ 1828345931850842112
author Tiziana Triulzi
Patrizia Casalini
Marco Sandri
Manuela Ratti
Maria L Carcangiu
Mario P Colombo
Andrea Balsari
Sylvie Ménard
Rosaria Orlandi
Elda Tagliabue
author_facet Tiziana Triulzi
Patrizia Casalini
Marco Sandri
Manuela Ratti
Maria L Carcangiu
Mario P Colombo
Andrea Balsari
Sylvie Ménard
Rosaria Orlandi
Elda Tagliabue
author_sort Tiziana Triulzi
collection DOAJ
description We recently showed that differential expression of extracellular matrix (ECM) genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4) with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, β-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGFβ induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001). Cox models, estimated separately in grade I-II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3-7.0, p = 0.0098). Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT) genes in both grade I-II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III) phenotype. These findings support the key relevance of neoplastic and stroma interaction in breast cancer progression.
first_indexed 2024-04-14T00:18:43Z
format Article
id doaj.art-14d7e5aa0d9c4ad38cc6cfb38df659c5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T00:18:43Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-14d7e5aa0d9c4ad38cc6cfb38df659c52022-12-22T02:23:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5676110.1371/journal.pone.0056761Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.Tiziana TriulziPatrizia CasaliniMarco SandriManuela RattiMaria L CarcangiuMario P ColomboAndrea BalsariSylvie MénardRosaria OrlandiElda TagliabueWe recently showed that differential expression of extracellular matrix (ECM) genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4) with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, β-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGFβ induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001). Cox models, estimated separately in grade I-II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3-7.0, p = 0.0098). Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT) genes in both grade I-II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III) phenotype. These findings support the key relevance of neoplastic and stroma interaction in breast cancer progression.http://europepmc.org/articles/PMC3575489?pdf=render
spellingShingle Tiziana Triulzi
Patrizia Casalini
Marco Sandri
Manuela Ratti
Maria L Carcangiu
Mario P Colombo
Andrea Balsari
Sylvie Ménard
Rosaria Orlandi
Elda Tagliabue
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
PLoS ONE
title Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
title_full Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
title_fullStr Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
title_full_unstemmed Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
title_short Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
title_sort neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress
url http://europepmc.org/articles/PMC3575489?pdf=render
work_keys_str_mv AT tizianatriulzi neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT patriziacasalini neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT marcosandri neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT manuelaratti neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT marialcarcangiu neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT mariopcolombo neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT andreabalsari neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT sylviemenard neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT rosariaorlandi neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress
AT eldatagliabue neoplasticandstromalcellscontributetoanextracellularmatrixgeneexpressionprofiledefiningabreastcancersubtypelikelytoprogress